Anna Pagonakis

Array ( [id] => 8503221 [patent_doc_number] => 20120302630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/395700 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6658 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136481 [patent_doc_number] => 20110009383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'METHOD OF TREATING MIXED LINEAGE LEUKEMIA GENE-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIAS' [patent_app_type] => utility [patent_app_number] => 12/877604 [patent_app_country] => US [patent_app_date] => 2010-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1371 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009383.pdf [firstpage_image] =>[orig_patent_app_number] => 12877604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6618579 [patent_doc_number] => 20100324083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Combinations of Organic Compounds' [patent_app_type] => utility [patent_app_number] => 12/862979 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 10754 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324083.pdf [firstpage_image] =>[orig_patent_app_number] => 12862979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6631871 [patent_doc_number] => 20100311805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'COMBINATION OF HISTONE DEACETYLASE INHIBITORS AND RADIATION' [patent_app_type] => utility [patent_app_number] => 12/852770 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9246 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311805.pdf [firstpage_image] =>[orig_patent_app_number] => 12852770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937616 [patent_doc_number] => 20110212975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THEREOF' [patent_app_type] => utility [patent_app_number] => 12/850806 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17386 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212975.pdf [firstpage_image] =>[orig_patent_app_number] => 12850806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6162860 [patent_doc_number] => 20110160130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'CANCER TREATMENT METHOD' [patent_app_type] => utility [patent_app_number] => 12/848379 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14267 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160130.pdf [firstpage_image] =>[orig_patent_app_number] => 12848379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317542 [patent_doc_number] => 08232318 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Approaches to treat cancer using HB-EGF inhibitors' [patent_app_type] => utility [patent_app_number] => 12/847509 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 13359 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12847509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149880 [patent_doc_number] => 20110021475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Compositions And Methods for Treatment Of Fibrosis' [patent_app_type] => utility [patent_app_number] => 12/841611 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8853 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021475.pdf [firstpage_image] =>[orig_patent_app_number] => 12841611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954162 [patent_doc_number] => 20110034459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => '6,7-DIALKOXY QUINAZOLINE DERIVATIVES AND METHODS OF TREATING DRUG RESISTANT AND OTHER TUMORS' [patent_app_type] => utility [patent_app_number] => 12/833789 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16245 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034459.pdf [firstpage_image] =>[orig_patent_app_number] => 12833789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196715 [patent_doc_number] => 20110028473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'METHODS OF TREATING DRUG RESISTANT AND OTHER TUMORS BY ADMINISTERING 6,7-DIALKOXY QUINAZOLINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/833733 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12994 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028473.pdf [firstpage_image] =>[orig_patent_app_number] => 12833733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328764 [patent_doc_number] => 08236860 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Inhibition of the survival of pancreatic cancer by cyclohexenone compounds from Antrodia camphorata' [patent_app_type] => utility [patent_app_number] => 12/832548 [patent_app_country] => US [patent_app_date] => 2010-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2921 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12832548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560199 [patent_doc_number] => 08334262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Cognitive function' [patent_app_type] => utility [patent_app_number] => 12/827935 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 7194 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12827935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6237029 [patent_doc_number] => 20100267818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'STABILIZED SINGLE-LIQUID PHARMACEUTICAL COMPOSITION CONTAINING DOCETAXEL' [patent_app_type] => utility [patent_app_number] => 12/826278 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5590 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267818.pdf [firstpage_image] =>[orig_patent_app_number] => 12826278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352675 [patent_doc_number] => 20100331386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'ENANTIOMERS OF SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/825168 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22012 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331386.pdf [firstpage_image] =>[orig_patent_app_number] => 12825168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6275830 [patent_doc_number] => 20100256141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'NOVEL BIS-AZAINDOLE DERIVATIVES, PREPARATION AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/821371 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55980 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256141.pdf [firstpage_image] =>[orig_patent_app_number] => 12821371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6098070 [patent_doc_number] => 20110003877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'SMAC Mimetic' [patent_app_type] => utility [patent_app_number] => 12/819221 [patent_app_country] => US [patent_app_date] => 2010-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18361 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003877.pdf [firstpage_image] =>[orig_patent_app_number] => 12819221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351881 [patent_doc_number] => 20100331315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/819091 [patent_app_country] => US [patent_app_date] => 2010-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39665 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331315.pdf [firstpage_image] =>[orig_patent_app_number] => 12819091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003077 [patent_doc_number] => 20110118255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JAK2 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/817785 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24383 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118255.pdf [firstpage_image] =>[orig_patent_app_number] => 12817785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097706 [patent_doc_number] => 20110003801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'BENZIMIDAZOLE DERIVATIVES USEFUL AS TRPM8 CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/797743 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15226 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003801.pdf [firstpage_image] =>[orig_patent_app_number] => 12797743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9524229 [patent_doc_number] => 08748494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Method for improving the therapeutic efficacy of curcuminoids and their analogs' [patent_app_type] => utility [patent_app_number] => 12/797059 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11129 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12797059 [rel_patent_id] =>[rel_patent_doc_number] =>)